Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maiden Biosciences develops and markets FDA-regulated collagen-based topical wound dressings for chronic and acute wound management. Their products are designed to optimize healing by maintaining a moist environment and supporting tissue regeneration. The company’s offerings include collagen powder dressings, sheet dressings in various sizes—including transparent options—and silicone foam secondary dressings. These products are used in clinical settings for a range of exudating wounds including diabetic foot ulcers, venous leg ulcers, pressure sores, burns, surgical sites, abrasions and lacerations. Clinical results emphasize improved healing environments with reduced scarring and discomfort.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maiden.